|
Hepatic arterial infusion (HAI) chemotherapy via the medtronic pump-assessing dose delivery, response rates and toxicity. |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - Physicans' Education Resource |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Honoraria - Celgene; Ethicon; Ipsen; Shire |
Consulting or Advisory Role - Celgene; Ethicon; Ipsen; Shire |
Speakers' Bureau - Celgene; Celgene; Shire |
Research Funding - Celgene (Inst) |
Travel, Accommodations, Expenses - Bayer; Bayer; Shire |
Other Relationship - Cancer Care Ontario |
|
|
No Relationships to Disclose |
|
|
|